Research from Dr. Julian Davies lab featured on ASM

Kisameet clay exhibits potent antibacterial activity against the ESKAPE pathogens

A clique of six pathogenic microorganisms (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) termed 'the ESKAPE pathogens' are responsible for a majority of hospital-acquired infections. Due to their capability to avoid the biocidal action of antibiotics and the immune response, they present critical threats in nosocomial pathogenesis worldwide and their therapeutic choices are extremely limited.    A publication from Davies laboratory (mBio 7(1):e01842-15. doi:10.1128/mBio.01842-15. 26 January 2016) reports that Kisameet clay, a natural clay mineral from the central coast of British Columbia, Canada, northwest of Vancouver, exhibits broad-spectrum and potent antibacterial activity against a collection of 16 multi-drug resistant ESKAPE strains in vitro. The results suggest that this natural clay might have potential as a therapeutic option for curing infections caused by these important clinical pathogens.

The Davies’ lab finding that extracts from the Kismaeet “healing” clay can kill multiple strains of antibiotic-resistant bacteria (ESKAPE strains) is featured on other websites as well:

The UBC News website:

The Faculty of Science website’-ancient-medicinal-clay-shows-promise-against-today’s-worst-bacterial-infections

In a press release from the American Society for Microbiology

Congratulations to Julian and M&I grad student Shekooh Behroozian, who is the first author on this paper.